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Abstract
Background: Older patients undergoing surgery tend to have a higher frequency of delirium. Delirium is strongly
associated with poor surgical outcomes. This study evaluated the association between pre-operative medication
use and post-operative delirium (POD) in surgical oncology patients receiving comprehensive geriatric assessment
(CGA).
Methods: A total of 475 patients who were scheduled for cancer surgery and received CGA from January
2014 to June 2015 were included. Pre-operative medication review through CGA was conducted on
polypharmacy (≥5 medications), delirium-inducing medications (DIMs), fall-inducing medications (FIMs), and potentially
inappropriate medications (PIMs). POD was confirmed by psychiatric consultation, and DSM-V criteria were used for
diagnosing delirium. The model fit of the prediction model was assessed by computing the Hosmer-Lemeshow
goodness-of-fit test. Effect size was measured using the Nagelkerke R2. Discrimination of the model was assessed by an
analysis of the area under receiver operating curve (AUROC).
Results: Two models were constructed for multivariate analysis based on univariate analysis; model I included
dementia and DIM in addition to age and sex, and model II included PIM instead of DIM of model I. Every one year
increase of age increased the risk of POD by about 1.1-fold. DIM was a significant factor for POD after adjusting for
confounders (AOR 12.78, 95 % CI 2.83-57.74). PIM was also a significant factor for POD (AOR 5.53, 95 % CI 2.03-15.05).
The Hosmer-Lemeshow test results revealed good fits for both models (χ2 = 3.842, p = 0.871 for model I and χ2 = 8.130,
p = 0.421 for model II). The Nagelkerke R2 effect size and AUROC for model I was 0.215 and 0.833, respectively. Model II
had the Nagelkerke R2effect size of 0.174 and AUROC of 0.819.
Conclusions: These results suggest that pharmacists’ comprehensive review for pre-operative medication use is critical
for the post-operative outcomes like delirium in older patients.
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Background
In Korea, the proportion of the population aged 65 years
or over in 2014 was 12.7 %. By 2030, that will increase
to 24.3 % and is expected to rise to 32.3 % by 2040. The
most common cause of death in those ≥ 65 years of age
in 2013 was cancer [1]. The proportion of older patients
with cancer diagnosis and subsequent surgery is also
increasing.
Older patients suffer from comorbid diseases and have
a high risk of post-operative complications [2–4]. In par-
ticular, older cancer patients have a high prevalence of
comorbidities (53 ~ 60 %). Among post-operative com-
plications, older patients undergoing surgery tend to
have a higher frequency of delirium [5]. Delirium is
strongly associated with poor surgical outcomes. In the
hospital, post-operative delirium (POD) is associated
with a 2- to 5-fold increased risk of major post-operative
complications, including an increased risk of death [5].
Patients on chronic drugs unrelated to their surgical
procedure are more likely to have post-operative compli-
cations [6]. Older cancer patients, in particular, have a
high prevalence of comorbidities (53 ~ 60 %) and take a
variety of medications. It’s been reported that the pro-
portions of polypharmacy and potentially inappropriate
medication (PIM) users among older cancer patients
were 84 and 51 %, respectively [7–9]. Pre-operative com-
prehensive geriatric assessment (CGA) is used to assess
medication review in addition to comorbidities, func-
tional status, cognitive function, nutritional status, and
socioeconomic issues [10].
Pre-operative CGA can predict post-operative morbidity
and mortality in older patients undergoing surgery as well
as effects on the treatment plan [11, 12]. Although effect-
iveness of CGA as a prediction tool of adverse post-
operative outcomes (i.e., identifying older patients at a
greater risk of mortality, post-discharge institutionalization,
adverse in-hospital events, and prolonged length of hospital
stay) of older patients who are scheduled for cancer surgery
in particular, has been proven, studies on the relationship
between pre-operative use of medication and post-
operative outcomes are rare. Considering that polyphar-
macy and use of psychotropic medications such as benzodi-
azepines, anticholinergics, antihistamines, antipsychotics
are known to induce POD, pre-operative medication use
should be evaluated as one of important markers to predict
post-operative outcomes in CGA [13, 14]. Therefore, this
study was to evaluate the association between pre-operative
medication use and POD.
Methods
Study population and data collection
All patients ≥ 65 years of age scheduled for cancer sur-
gery were eligible in this study. We retrospectively stud-
ied consecutive subjects ≥ 65 years of age who were
scheduled for cancer surgery and presented for pre-
operative CGA at the geriatric center of Seoul National
University Bundang Hospital between January 2014 and
June 2015. We excluded patients who refused surgery or
did not have cancer surgery.
Baseline patient characteristics collected from elec-
tronic medical records included age, sex, height, weight,
cancer type, and comorbidities. Serum creatinine, lean
body weight, sex, and age were used to estimate renal
function by Cockcroft-Gault equation. The risk of delir-
ium was measured by the Nursing Delirium Screening
Scale, with scores ranging from 0 to 5; a score of 2 or
higher suggests an increased risk of POD [15].
Cognitive function evaluation and pre-operative medica-
tion review in CGA
Pre-operative CGA was performed using an established
tool by the geriatric team, which consisted of geriatricians,
nurse specialists, dietitians, and pharmacists. Pharmacists
were wholly responsible for the drug assessment. Cognitive
function was evaluated using the Korean version of the
Mini-Mental Status Examination (MMSE-KC), with scores
ranging from 0 to 30 (dementia is a score < 17) [16].
Medication review was performed as follows; 1) Pa-
tients were guided to carry records of their medications
(prescriptions) or their actual medications in advance of
CGA. 2) Pharmacists interviewed patients and caregivers
to figure out all prescription and non-prescription medi-
cations. Information of PRN use was also obtained. In
the process, pharmacists recorded number of medica-
tions, pre-operative discontinuation-requiring medica-
tions (PDRMs), delirium-inducing medications (DIMs),
fall-inducing medications (FIMs), and PIMs.
PDRMs were defined as medications that should be
discontinued before surgery due to surgical risks, such
as antithrombotic agents for post-operative hemorrhage,
metformin for lactic acidosis, exogenous hormones for
venous thromboembolism, and herbal medications for
the uncertainty over their actual contents (Table 1).
DIMs were medications whose adverse events, such as
delirium, confusion or hallucination, were reported over
1 % by the drug information database Micromedex®.
Deliriants including high dose narcotics, benzodiaze-
pines, and anticholinergic medications were also in-
cluded in DIMs (Table 1) [17]. Antihypertensive agents,
diuretics, glucose lowering agents, antihistamines, laxa-
tives, antipsychotics, neuroleptics, antidepressants, hyp-
notics and sedatives, and opioids were classified as FIMs
(Table 1) [18]. PIMs were determined according to the
2015 Beers criteria [19]. Levosulpiride (prokinetic agents
available in Korea) was included, although it is not listed
in the Beers criteria, because it frequently causes drug-
induced movement disorders [20] and since safer alter-
natives are available (Table 1) [21].
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Number of medications was counted by the number of
active ingredients. Multi-component digestives, antacids,
multivitamins, or herbal extracts were regarded as one
ingredient because they have a single effect. Topical
drugs and eye drops were not included because they
rarely induce systemic adverse events. Polypharmacy was
defined as taking more than five medications [22, 23].
Delirium after operation was determined by psychi-
atric consultation, and DSM-V criteria were used for
diagnosis of delirium [24].
Statistical analyses
The Mann–Whitney-U-test was used to compare con-
tinuous variables between patients with and without
POD, and the chi-square test was used for categorical
variables. Multivariable logistic regression analysis was
used to identify independent risk factors for POD. Fac-
tors having p-values < 0.05 from univariate analysis along
with strong confounders of age and sex were included in
the multivariate analysis. Variables were entered by step-
wise selection for p < 0.05 and were removed for p > 0.1.
Odds ratio (OR) and adjusted odds ratio (AOR) were
calculated from univariate and multivariate analyses,
respectively. P-values less than 0.05 were considered sta-
tistically significant.
The model fit of the prediction model was assessed by
computing the Hosmer-Lemeshow goodness-of-fit test.
Effect size was measured using the Nagelkerke R2. Dis-
crimination of the model was further assessed by an ana-
lysis of the area under receiver operating curve
(AUROC), which assesses the ability of the risk factor to
predict POD. All statistical analyses were carried out
using the Statistical Package for Social Sciences version
17.0 for Windows (SPSS Inc., Chicago, IL, USA).
Results
A total of 527 patients were scheduled for cancer sur-
gery and received CGA from January 2014 to June 2015.
Fifty two patients were excluded due to refusal for sur-
gery (n = 35), changed treatment plan (n = 13), and age <
65 years (n = 4). Accordingly, data from 475 cancer pa-
tients who underwent pre-operative CGA and cancer
surgery were used for the analysis.
As shown in Table 2 and Additional file 1, patients’ me-
dian age was 76 years (range 65–96); 281 patients (59.2 %)
were ≥ 75 years of age and 120 (25.3 %) were ≥ 80 years of
age. About 55 % of the study patients were women. More
Table 1 Pre-operative medications reviewed for comprehensive geriatric assessment in this study
Pre-operative discontinuation-requiring medications
Aceclofenac, Anastrozole, Artemisia asiatica extract, Aspirin, Avocado-soya titrated extract, Beraprost, Celecoxib, Cilostazol, Cimicifugae rhizoma extract, Clopido-
grel, Coptis rhizome extract, Dabigatran, Dalteparin, Dexibuprofen, Ginkgo biloba Leaf extract, Hedera helicis folia extract, Hypericum extract, Ibudilast,
Ibuprofen, Indobufene, Clematidis Radix/Trichosanthes Root/Prunella Spike Extract, Kallidinogenase, Letrozole, Limaprost, Loxoprofen, Mefenamic acid,
Meloxicam, Mesoglycan, Metformin, Milk-thistle extract, Motilitone, Nafronyl oxalate, Naproxen, Nicergoline, Pelargonium sidoides extract, Petasites hybridus
folium extract, Phellinus linteus extract, Raloxifene, Rivaroxaban, Sarpogrelate, Streptokinase/Streptodornase, Sulodexide, Talniflumate, Tibolone, Triflusal,
Vaccinium myrtillus extract, Vitis vinifera extract, Warfarin, Zea mays L. titrated extract, Angelica extract
Delirium-inducing medications
Alprazolam, Amantadine, Amitriptyline, Atenolol, Benserazide/Levodopa, Bicalutamide, Bisoprolol, Buspirone, Carbamazepine, Carbidopa, Celecoxib,
Chlordiazepoxide, Chlorpheniramine, Cimetidine, Ciprofloxacin, Clonazepam, Clotiazepam, Cyproheptadine, Diazepam, Digoxin,
Dimenhydrinate, Divalproex, Donepezil, Entacapone, Etizolam, Famotidine, Fentanyl, Flurazepam, Gabapentin, Hydromorphone, Hydroxyzine,
Ibuprofen, Imipramine, Lafutidine, Levofloxacin, Lorazepam, Meloxicam, Memantine, Morphine, Nizatidine, Nortriptyline, Orphenadrine,
Oxycodone, Pramipexole, Prednisolone, Pregabalin, Procyclidine, Propranolol, Quetiapine, Ranitidine, Rivastigmine, Ropinirole, Scopolamine,
Tiropramide, Tramadol, Trazodone, Triazolam, Valproate, Zolpidem
Fall-inducing medications
Agiocur pregranule, Acarbose, Alfuzosin, Alogliptin, Alprazolam, Amitriptyline, Amlodipine, Amosulalol, Arotinolol, Atenolol, Azelastine, Barnidipine,
Benidipine, Bepotastine, Bisoprolol, Bromazepam, Calcium polycarbophil, Candesartan, Carbamazepine, Carvedilol, Cetirizine, Chlordiazepoxide/
Clidinium, Chlorpheniramine, Chlorpromazine, Chlorthalidone, Cilnidipine, Clonazepam, Clotiazepam, Codeine, Desloratadine, Diazepam, Diltiazem,
Dimenhydrinate, Divalproex, Doxazosin, Doxylamine, Duloxetine, Efonidipine, Enalapril, Epinastine, Eprosartan, Escitalopram, Etizolam, Felodipine,
Fentanyl, Fexofenadine, Fimasartan, Flunitrazepam, Flurazepam, Furosemide, Gabapentin, Gemigliptin, Glibenclamide, Gliclazide, Glimepiride,
Hydrochlorothiazide, Hydromorphone, Hydroxyzine, Hypericum extract, Imipramine, Indapamide, Insulin, Irbesartan, Isradipine, Lactulose,
Lercanidipine, Levocetirizine, Levosulpiride, Linagliptin, Loratadine, Lorazepam, Losartan, Magnesium oxide, Mequitazine, Metformin, Mirtazapine,
Morphine, Naftopidil, Nateglinide, Nebivolol, Nifedipine, Nortriptyline, Olmesartan, Olopatadine, Oxycodone, Paroxetine, Perindopril, Perphenazine,
Pioglitazone, Piprinhydrinate, Pregabalin, Propranolol, Prucalopride, Quetiapine, Ramipril, Saxagliptin, Sertraline, Sitagliptin, Spironolactone, Telmisartan,
Terazosin, Tianeptine, Torsemide, Trazodone, Triazolam, Triprolidine, Valproate, Valsartan, Venlafaxine, Verapamil, Vildagliptin, Voglibose, Zolpidem
Potentially inappropriate medications
Aceclofenaca, Alprazolam, Amitriptyline, Bromazepam, Chlordiazepoxide/clidinium, Chlorpheniramine, Chlorpromazine, Cimetropium,
Clonazepam, Clotiazepam, Cyproheptadine, Desmopressin, Dexibuprofena, Diazepam, Digoxin, Dimenhydrinate, Doxylamine, Etizolam,
Flunitrazepam, Flurazepam, Glibenclamide, Hydroxyzine, Imipramine, Levosulpiride, Lorazepam, Megestrol, Meloxicama, Metoclopramide,
Naproxena, Nortriptyline, Orphenadrine, Paroxetine, Perphenazine, Piprinhydrinate, Quetiapine, Scopolamine, Talniflumatea, Testosterone,
Triazolam, Triprolidine, Zolpidem
aChronic use
Drugs written in bold font are those which are included in both delirium-inducing and potentially inappropriate medications
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Table 2 Association of pre-operative medication use with post-operative delirium
Characteristics No (%) Delirium No (%) P
Presence (n = 19) Absence (n = 456)
Age (years) 0.018
Median (range) 76.0 (65.0–96.0) 79.0 (71.0–89.0) 76.0 (65.0–96.0)
Sex 0.157
Male 215 (45.3) 12 (63.2) 203 (44.5)
Female 260 (54.7) 7 (36.8) 253 (55.5)
BMI (kg/m2)a 0.054
Median (range) 23.6 (15.0–40.4) 21.9 (15.6–35.1) 23.7 (15.0–40.4)
CVD presenceb 0.609
Yes 343 (72.2) 15 (78.9) 328 (71.9)
No 132 (27.8) 4 (21.1) 128 (28.1)
Diabetes Presence 1.000
Yes 125 (26.3) 5 (26.3) 120 (26.3)
No 350 (73.7) 14 (73.7) 336 (73.7)
Dementia Presence 0.026
Yes 17 (3.6) 3 (15.8) 14 (3.1)
No 458 (96.4) 16 (84.2) 442 (96.9)
CrCla 0.776
≥50 mL/min 96 (21.1) 3 (15.8) 93 (21.3)
<50 mL/min 359 (78.9) 16 (84.2) 343 (78.7)
Cancer Type 0.179
Gastrointestinal 353 (74.3) 17 (89.5) 336 (73.7)
Othersc 122 (25.7) 2 (10.5) 120 (26.3)
Delirium Risk Scored 0.119
0–1 454 (96.8) 17 (89.5) 437 (97.1)
≥2 15 (3.2) 2 (10.5) 13 (2.9)
Polypharmacy 0.159
Yes 240 (50.5) 13 (68.4) 227 (49.8)
No 235 (49.5) 6 (31.6) 229 (50.2)
PDRM 1.000
Yes 272 (57.3) 11 (57.9) 261 (57.2)
No 203 (42.7) 8 (42.1) 195 (42.8)
DIM <0.001
Yes 200 (42.1) 17 (89.5) 183 (40.1)
No 275 (57.9) 2 (10.5) 273 (59.9)
FIM 0.091
Yes 365 (76.8) 18 (94.7) 347 (76.1)
No 110 (23.2) 1 (5.3) 109 (23.9)
PIM <0.001
Yes 127 (26.7) 12 (63.2) 115 (25.2)
No 348 (73.3) 7 (36.8) 341 (74.8)
BMI body mass index, CVD cardiovascular disease, CrCl creatinine clearance, PDRM pre-operative discontinuation requiring medication, DIM delirium-inducing
medication, FIM fall-inducing medication, PIM potentially inappropriate medication
aThere were 20 missing data for BMI and CrCl
bCVD included hypertension, ischemic heart disease (unstable angina, stable angina, myocardiac infarction), dyslipidemia, heart failure, atrial fibrillation, and cerebral infarction
cOthers included 93 breast cancer, 15 gynecology cancer, 5 genitourinary cancer, and 9 other cancer patients
dThere were 6 missing data for delirium risk score
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than 70 % of patients had cardiovascular diseases and
17 patients (3.6 %) had dementia. More than two-
thirds of patients had creatinine clearance < 50 mL/
min. Patients had gastrointestinal cancer (n = 353),
breast cancer (n = 93), gynecology cancer (n = 15),
genitourinary cancer (n = 5), and other cancers (n = 9).
Delirium score ≥ 2 was found in 3.2 % of patients.
Around half of patients had polypharmacy (50.5 %),
PDRM (57.3 %), and DIM (42.1 %). Patients on FIM
and PIM comprised 76.8 % and 26.7 %, respectively.
POD was diagnosed in 19 patients (4 %). Patients who
experienced POD were older than those without POD
(p = 0.018). Among comorbidities, dementia had a sig-
nificant relationship with POD; patients with POD had
more than five times higher proportion of dementia
presence compared to those without POD (p = 0.026).
Low BMI was associated with POD with marginal
significance (p = 0.054).
More than two-fold patients in the POD group took
DIM and PIM before operation (p < 0.001). Patients in
POD group took more multiple medications and FIM
rather than patients in no POD group, although statis-
tical significance was not obtained.
As presented in Table 3, age, dementia, DIM, and PIM
were significant factors for POD in the univariate ana-
lysis. Since there was multicollinearity between DIM and
PIM, two models were constructed for the multivariate
analysis. Model I included dementia and DIM in
addition to age and sex, and model II included PIM
instead of DIM of model I.
Age was a significant factor for POD. For every one
year increase in age, the risk of POD increased about
1.1-fold in both models. No significant association was
found between dementia and POD in both models. DIM
(AOR 12.78, 95 % CI 2.83-57.74) and PIM (AOR 5.53,
95 % CI 2.03-15.05) were significant factors for POD
after adjusting for confounders.
The Hosmer-Lemeshow test for model I, which included
age, sex and DIM, revealed a good fit (χ2 = 3.842, p = .871).
The Nagelkerke R2 effect size was 0.215 and AUROC was
0.833 (Fig. 1a). In model II, which included age, sex, and
PIM, the Hosmer-Lemeshow test also revealed a good fit
(χ2 = 8.130, p = .421), and the Nagelkerke R2effect size was
0.174. AUROC was 0.819 (Fig. 1b).
Discussion
The main findings of this study are that one year in-
crease in age increased risk of POD by about 1.1-fold,
males had higher risk of POD (AORs of 2.8-2.9), patients
with DIM had 12.8 times (95 % CI 2.8-57.7) increased
risk of POD after adjusting for confounders, and patients
with PIM had 5.5-fold (95 % CI 2.0-15.1) increased risk
of POD after adjusting for covariates.
Consistent with our results, many studies showed that
old age is significantly associated with POD [25–27]. One
study reported that patients with POD were older than
those without POD (median age 82 vs 74, p < 0.001) simi-
lar to our results (79 vs 76, p < 0.05) [28]. Another study
on patients without dementia revealed that age was a
Table 3 Univariate and multivariate regression analyses to identify predictors for post-operative delirium
Characteristics Unadjusted OR (95 % CI) Adjusted OR (95 % CI) Adjusted OR (95 % CI)
Model I Model II
Age 1.117 (1.029–1.212)** 1.098 (1.005–1.199)* 1.098 (1.006–1.199)*
Male 2.137 (0.826–5.526) 2.776 (1.029–7.490)* 2.921 (1.056–8.081)*
BMI 0.868 (0.752–1.002)
CVD 1.463 (0.477–4.493)
Diabetes Mellitus 1.000 (0.353–2.835)
Dementia 5.906 (1.542–22.675)** 2.135 (0.507–8.998) 3.860 (0.886–16.806)
CrCl < 50 mL/min 1.446 (0.413–5.069)
GI Cancer 3.036 (0.691–13.335)
Delirium Risk Score ≥2 3.955 (0.826–18.925)
Polypharmacy 2.186 (0.817–5.851)
PDRM 1.027 (0.406–2.602)
DIM 12.680 (2.895–55.541)*** 12.775 (2.826–57.741)***
FIM 5.654 (0.746–42.843)
PIM 5.083 (1.955–13.220)*** 5.525 (2.028–15.054)***
For model I construction, age, sex, dementia, and DIM were included for analysis. For model II construction, age, sex, dementia, and PIM were included for analysis
BMI body mass index, CVD cardiovascular disease, CrCl creatinine clearance, PDRM pre-operative discontinuation requiring medication, DIM delirium-inducing
medication, FIM fall-inducing medication, PIM potentially inappropriate medication
*P < 0.05, **P < 0.01, ***P < 0.001
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predictor for POD (OR 1.1, 95 % CI 1.0-1.1), which is al-
most same as our result (AOR 1.1, 95 % CI 1.0-1.2) [29].
The association between male sex and POD is unclear.
Studies on patients undergoing elective orthopedic sur-
gery reported that male sex was a significant predictor
for delirium, but only in patients without dementia [30,
31]. A systematic review of pre-operative risk factors for
delirium after non-cardiac surgery also concluded that
there is lack of evidence to support an association be-
tween male sex and delirium [26]. However, the study
had significant heterogeneity across the study samples.
Our study population was a homogeneous group with
surgical oncology; around 3-fold increased risk with
male sex compared to female sex was evident. One pos-
sible explanation of the higher incidence of POD in men
was that men were more likely to exhibit the hyperactive
form of delirium, and the incidence of hypoactive type
of delirium could be underestimated due to the retro-
spective design of this study [32].
DIM was the strongest factor for POD in this study.
More than 12-times higher risk of POD was found in
pre-operative DIM users. Many studies support our re-
sults. In a study using Japanese population receiving
lung and esophageal cancer surgery, use of benzodiaze-
pines was a significant factor for POD (OR 4.0, 95 % CI
1.1-14.5) [33]. Another study also showed that signifi-
cant association between pre-operative benzodiazepine
use and POD (OR 3.0, 95 % CI 1.3-6.8) [34]. Around a
12-fold higher risk of POD was reported for users of
propranolol, scopolamine, and flurazepam, which are in-
cluded in our DIM list [35].
The American Geriatrics Society Guideline recom-
mends PIM should be avoided in older patients due to
the risk of POD [36]. Our study implicated PIM as an
independent factor for POD. However, more than half
drugs included in PIM list are DIM. Therefore, the effect
of PIM on POD could be partially attributable to the
property to induce delirium in several drugs. To esti-
mate the effects of drugs included in both DIM and
PIM, we further evaluated the association between 22
drugs included in both DIM and PIM and POD (Table 1).
The OR and AOR of the 22 drugs for POD was 6.3 (95
% CI 2.4-16.1) and 8.4 (95 % CI 3.0-23.6), respectively.
Therefore, drugs inducing delirium among PIM need to
be more closely monitored for prevention of POD.
The model including DIM was also higher effect size
(21.5 %) than that including PIM (17.4 %), although the
sizes were small. However, the Hosmer-Lemeshow test
results showed that the fits of both models were satisfac-
tory. Moreover, our models had an AUROC of around
0.8, indicating that the ability of the two models to pre-
dict is much better than by chance alone (0.5). An
AUROC > 0.7 for the models indicated that they had ac-
ceptable capacities for patients with POD as compared
to those without POD [37].
To the best of our knowledge, this is the first study to
develop prediction models by pre-operative medication
use for POD and validate them using various statistical
tools, such as the Hosmer-Lemeshow goodness-of-fit
test, Nagelkerke R2, and AUROC.
However, this study has several limitations. First, the
incidence of POD could be underestimated due to the
definition of POD. Previous studies reported the fre-
quency of POD in older patients as 9–29 % [25, 26]. The
present incidence of 4 % was much less. Our study de-
fined POD more strictly; POD in our study was deter-
mined with diagnosis by competent psychiatrists based
on DSM-V criteria. It’s been reported that variations in
definition, comorbid conditions, details related to sur-
gery, diagnosticians, and diagnostic tools used are factors
Fig. 1 Area under receiver operating characteristic curve for post-operative delirium occurrence. a Model I included age, sex, and delirium-inducing
medications for analysis. b Model II included age, sex, and potentially inappropriate medications for analysis
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influencing incidence rates [38]. Therefore, study results
could be primarily applied to patients with confirmed
delirium diagnosis after cancer surgery using DSM-V by
psychiatrists. Second, because of the retrospective study
design, the incidence of hypoactive type of delirium
might have been underestimated. Third, the adjusted
odds ratio of DIM and PIM were very high because con-
founding effects of unmeasured comorbidities were pos-
sibly included. Therefore, our hypothesis requires
further independent validation using more robust pro-
spective designs.
In spite of the shortcomings, this study provides com-
pelling evidence for the importance of assessing pre-
operative medication. The results of this study could be
utilized to develop and implement individually tailored
geriatric interventions to prevent POD. Moreover, the
predictive value of CGA could be greater because con-
firmed cases of delirium were only included in this
study.
Conclusions
The exposure to DIM and PIM in older patients before
cancer surgery was associated with increased incidence
of POD. This is an important finding, and should be
considered in the preoperative assessment of older pa-
tients, preferably by interdisciplinary teamwork includ-
ing a pharmacist.
Additional file
Additional file 1: Table S1. Raw data for the study of association
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assessment; DIM, delirium-inducing medication; FIM, fall-inducing medication;
PDRM, pre-operative discontinuation requiring medication; PIM, potentially
inappropriate medication; POD, post-operative delirium.
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